Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
NCT05933278
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
BIOLOGICAL:
SARS-CoV-2 Subunit Recombinant Protein Vaccine
Sponsor
PT Bio Farma